HHS Vaccine Expert Protests over Transfer; Claims Retaliation over Hydroxychloroquine; Hires Anti-Kavanaugh Attorneys
Dr. Rick Bright, former director of the Biomedical Advanced Research and Development Authority (BARDA) at the U.S. Department of Health and Human Services, protested Wednesday after being reassigned to the National Institutes of Health — in retaliation, he claims, for his reluctance to fast-track approval for hydroxycholorquine for treating coronavirus patients.